Directa Plus Regulatory News (DCTA)

18 October 2016

Directa Plus plc

("Directa Plus" or the "Company")

Further Two Patents Granted Covering Graphene Plus Production

Directa Plus now has complete protection of entire G+ manufacturing process

Directa Plus (AIM: DCTA), a producer and supplier of graphene-based products for use in consumer and industrial markets, is pleased to announce that Ufficio Brevetti e Marchi (Italian Patent and Trademark Office) has issued notification that a further two patents have been granted covering Directa Plus' proprietary G+ manufacturing process. The Company now has a portfolio of 14 patents granted and eight pending.

Patent MI2014A001123: Process for preparing graphene nanoplatelets (GNPs) 

This patent covers the core of Directa Plus' G+ technology, the liquid exfoliation phase, where the Company's material passes from a 3D to 2D state.

Patent MI2014A001124L: Continuous process for preparing pristine GNPs

This patent covers the entire production process of G+ pristine GNPs, which comprises natural graphite expansion, exfoliation and drying to obtain different grades and physical forms of G+ materials.

The patent is focused on the continuous character of the process while maintaining its inherent flexibility for the production of customised graphene-based products. The whole production process does not involve the use of any type of chemistry nor oxidation steps, therefore providing pure materials already certified as non-toxic for human health.

Giulio Cesareo, Chief Executive Officer of Directa Plus, said: "Our intellectual property is a key value driver for the business and so the continued widening of our patent protection is very important to us. It is a major step forward to achieve high volume production at a very low cost. These patents offer us excellent protection as we continue to see the commercial launch of more and more end-user products containing our technology."

Enquiries